文献速递糖尿病

加州2022年医疗补助扩展后初级保健2型糖尿病药物变化

Changes in Type 2 Diabetes Medications Among Primary Care Patients After California's 2022 Medicaid Expansion.
PubMed 文献 · Diabetes Care · 2026-01-01

研究评估加州2022年5月将全额医疗补助扩展至50岁以上低收入无证移民后,是否增加新型2型糖尿病药物处方。使用洛杉矶县两个联邦合格健康中心2019年1月至2023年6月记录,比较三组患者。结果显示扩展后老年无证移民新型药物处方月增率比有证患者高6%,期末处方水平相近。

要点

  • 医疗补助扩展与老年无证移民新型降糖药处方增加相关。
  • 基线时无证移民新型药物处方几率显著低于有证患者。
  • 扩展后期末老年无证移民处方水平与有证患者相似。

核心结论

  • 医疗补助扩展有效改变了老年无证移民2型糖尿病患者的处方模式。
  • 尽管老年无证移民新型药物处方水平仍低于有证移民,但研究期末达到与有证患者相似水平。

研究设计与样本

  • 研究使用洛杉矶县两个联邦合格健康中心2019年1月至2023年6月患者记录,共20420次就诊和4601名患者。
  • 比较三组:新符合医疗补助资格的老年无证移民、不符合资格的年轻无证移民和有证患者。
  • 采用广义线性混合模型(患者水平随机截距)分析处方新型药物的可能性差异及时间变化。

主要发现

  • 基线时老年和年轻无证患者被处方新型药物类别的几率均显著低于有证患者。
  • 所有患者新型2型糖尿病药物处方随时间增加。
  • 老年无证组每月处方几率增加率比有证患者组高6%。

临床怎么用

  • 医疗补助扩展可能促进老年无证移民获得新型2型糖尿病药物。
  • 临床中应关注无证移民患者的降糖药物可及性差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In May 2022, California expanded full-scope Medicaid (Medi-Cal) to low-income undocumented immigrants aged 50 years or older, which provided access to newer type 2 diabetes (T2D) medications. This study examined whether the expansion led to more prescriptions of newer therapies like glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among older undocumented immigrants. RESEARCH DESIGN AND METHODS: We used patient records between January 2019 to June 2023 from two Federally Qualified Health Centers (FQHCs) in Los Angeles County. We compared prescriptions among 1) older undocumented immigrants newly eligible for Medi-Cal, 2) younger undocumented immigrants not eligible for Medi-Cal, and 3) documented patients (n = 20,420 encounters and 4,601 patients). We used generalized linear mixed models with patient-level random intercepts to examine whether the patient groups differed in their likelihood of being prescribed newer medications and if there were changes over time. RESULTS: The odds of being prescribed newer classes of drugs was significantly lower for both the older and younger undocumented patients than documented patients at baseline. Prescriptions for newer T2D medications increased over time for all patients, but the monthly rate of increase in the odds was 6% higher for the older undocumented group compared with the documented patient group. CONCLUSIONS: Medi-Cal expansion was effective in changing prescription patterns for older undocumented immigrants with T2D. Although the older undocumented immigrants were prescribed newer drugs at a much lower level than were documented immigrants, they ended at a similar level as the documented patients by the end of the study period.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ro AE, Morales C, Jiang L, et al. Changes in Type 2 Diabetes Medications Among Primary Care Patients After California's 2022 Medicaid Expansion. Diabetes Care. 2026. PMID: 41191813. doi:10.2337/dc25-0787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。